Lennox Int'l (LII) Tops Q4 EPS by 7c; Reiterates Outlook
Tweet
Share
E-mailGet Alerts LII Hot Sheet
Price: $390.53 --0%
Revenue Growth %: +9.8%
Financial Fact:
NET SALES: 1.01B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +9.8%
Financial Fact:
NET SALES: 1.01B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Lennox Int'l (NYSE: LII) reported Q4 EPS of $1.50, $0.07 better than the analyst estimate of $1.43. Revenue for the quarter came in at $897 million versus the consensus estimate of $883.03 million.
GUIDANCE:
Reiterating guidance for 2017 revenue growth of 3-7% and EPS from continuing operations of $7.55-$8.15, versus the consensus of $7.85.
For earnings history and earnings-related data on Lennox Int'l (LII) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
- Erste Group Starts Marsh (MRSH) at Buy
- BMS myeloma CAR T therapy meets primary endpoint in phase 2 trial
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
